VRNA is currently covered by 4 analysts with average potential upside of $10.83 (112.2%) backed by 5 price targets and 15 ratings. Documented since 22-May-2017. Analyst's average stock valuation to be materialised ratio is 66.67% with an average time for price targets to be met of 611.5 days.
Most recent stock forecast was given by THOMAS SHRADER from BTIG on 20-Mar-2023.
Highest price target for VRNA is 23, Lowest price target is 4, average price target is 13.5.
Currently, out of the existing stock ratings of VRNA - 10 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
31
$10.37 (50.27%)
26
5 days ago
2/3 (66.67%)
$8.58 (47.82%)
1025
Buy
32
$11.37 (55.11%)
32
12 days ago
0/2 (0%)
$10.97 (53.77%)
Buy
23
$2.37 (11.49%)
18
7 months 16 days ago
3/3 (100%)
$12.06 (173.05%)
790
Buy
23
$2.37 (11.49%)
18
1 years 4 months 13 days ago
4/4 (100%)
$11.72 (174.15%)
631
What is VRNA(Verona Pharma plc) average time for price targets to be met?
Which analyst has the current highest performing score on VRNA(Verona Pharma plc) with a proven track record?
